SB 1911, the HEALTH Panel Act, would amend the Congressional Budget and Impoundment Control Act of 1974 to formally create a Panel of Health Advisors within the Congressional Budget Office (CBO). The panel’s purpose is to provide technical and functional expertise to help the CBO improve its studies, analyses, and cost estimates involving health and health care policy. It would focus on both economic and non-economic health policy analysis, including CBO models, official cost estimates for health legislation, and health-related sections of major CBO publications.
The bill sets out a detailed structure for the panel. It would have 15 members appointed by congressional budget leaders and the CBO director, with members serving as special government employees, staggered three-year terms, and a two-term limit. The CBO director would designate a chair and vice chair, and the panel would meet at least annually and submit a report to the House and Senate Budget Committees describing its work and any recommendations adopted by the CBO. The bill also allows the CBO director to establish conflict-of-interest disclosure procedures and confidentiality agreements for panel members.
In practical terms, the bill would add a formal advisory mechanism inside the CBO for health policy expertise, potentially affecting how federal health legislation is scored and how health-related budget and economic projections are developed. It would not directly change Medicare, Medicaid, or other program benefits, but it could influence the analytical basis Congress uses when considering health care legislation and federal health subsidies. The bill also amends the table of contents of the underlying budget law to include the new section.
The available context shows little recorded debate or opposition: the bill was introduced and referred to the Senate Committee on the Budget, with no committee transcript excerpts or votes provided. Based on the text, the measure appears to be a technical, process-oriented proposal aimed at improving CBO expertise rather than a substantive policy change. Any likely support would come from those favoring stronger health economics and actuarial input in federal budgeting, while possible concerns could center on panel composition, confidentiality, conflicts of interest, or the influence of outside experts on CBO work.
The bill would amend title II of the Congressional Budget and Impoundment Control Act of 1974 by adding a new section 204 establishing a Panel of Health Advisors within the CBO. It would create new reporting, appointment, membership, and ethics-related provisions affecting the CBO’s internal advisory structure and its health-related analytical products, but it would not directly alter substantive health program statutes such as Medicare or Medicaid.
The overall sentiment appears neutral to favorable, with the bill framed as a technical improvement to CBO capacity and health policy analysis. Because there are no recorded votes or committee discussion excerpts, there is no evidence of organized opposition or controversy in the available materials. The bill’s tone suggests an effort to strengthen expert input rather than advance a partisan policy change.
No specific contention is documented in the provided context. Potential points of debate, based on the bill text, could include how panel members are appointed, whether the panel’s recommendations could influence CBO neutrality, the handling of conflicts of interest, and confidentiality rules for members who may have industry or provider backgrounds. The bill’s broad qualifications list suggests a desire for diverse expertise, but that same breadth could raise concerns about representation and independence.